Skip to content
Health
Link copied to clipboard
Link copied to clipboard

A novel pill to treat bleeding from uterine fibroids aims for FDA approval

For millions of premenopausal women, uterine fibroids turn their monthly periods into virtual hemorrhages. A new drug called elagolix cut blood loss by half over six months in the overwhelming majority of women who participated in two clinical trials.

For millions of premenopausal women, uterine fibroids turn their monthly periods into virtual hemorrhages. A new drug called Orilissa cut blood loss by half over six months in the overwhelming majority of women who participated in two clinical trials.
For millions of premenopausal women, uterine fibroids turn their monthly periods into virtual hemorrhages. A new drug called Orilissa cut blood loss by half over six months in the overwhelming majority of women who participated in two clinical trials.Read moreCourtesy of AbbVie